Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.
D000284:Administration, Oral; D000374:Aggression / Q000187:drug effects*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature; D004298:Dopamine / Q000494:pharmacology*; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007274:Injections, Intraperitoneal; D009020:Morphine / Q000494:pharmacology; D009068:Movement / Q000187:drug effects; D051381:Rats; D011955:Receptors, Drug; D013997:Time Factors
D011955:Receptors, Drug; D009020:Morphine; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine